GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹ २,२६६.९०
arrow_upward
+०.९३%(+२०.९०) 1D
अक्टोबर १५, ११:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLENMARK...
Open
₹ २,२४२.००
High
₹ २,२८९.५०
Low
₹ २,२४१.२०
Mkt. cap
६.४० खरब
Avg. vol.
५.५४ लाख
Volume
२.३६ लाख
Dividend
०.२२%
Quarterly dividend
₹ १.२५
Ex-dividend date
२०२५ अक्टोबर ३
P/E ratio
३५.६०
52-wk high
₹ २,५३७.६०
52-wk low
₹ १,७९२.६०
EPS
₹ ६३.६८
Shares outstanding
०.००
No. of employees
१७ हजार
Open
₹ २,२४२.००
High
₹ २,२८९.५०
Low
₹ २,२४१.२०
Mkt. cap
६.४० खरब
Avg. vol.
५.५४ लाख
Volume
२.३६ लाख
Dividend
०.२२%
Quarterly dividend
₹ १.२५
Ex-dividend date
२०२५ अक्टोबर ३
P/E ratio
३५.६०
52-wk high
₹ २,५३७.६०
52-wk low
₹ १,७९२.६०
EPS
₹ ६३.६८
Shares outstanding
०.००
No. of employees
१७ हजार
News stories
From web sources and news partners
MarketBeat
·
१९ मिनेट पहिले
Plug Power (NASDAQ:PLUG) Hits New 1-Year Low Following Analyst Downgrade
Yahoo Finance
·
२ घण्टा पहिले
SKHY Tracks Worst Month Since Nasdaq Debut: SK Hynix Reportedly Wants To Ship More Chip Tools To China Before Building In US
www.marketscreener.com
·
५९ मिनेट पहिले
IPAS Indexo : INDEXO submits draft Company Description to Nasdaq Stockholm for preliminary review
Investor's Business Daily
·
२ घण्टा पहिले
Tech Futures Fall; Anthropic Revenue Jumps, But Not Enough?
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd